Qurin

Qurin is a research-driven diagnostics company specializing in non-invasive cancer detection through urine-based technologies. Headquartered in Leiden, the Netherlands, Qurin has developed a proprietary DNA extraction method that enables DNA extraction from large urine volumes, collected either at home or in point of care settings. This innovative approach yields high concentrations of DNA, significantly enhancing molecular analysis and increasing the likelihood of detecting signals from shedding primary or metastatic tumours that might otherwise go unnoticed. Beyond oncology, Qurin’s technology opens potential possibilities in areas such as protein and pathogen extraction. The company’s initial proof-of-concept will focus on early detection of bladder cancer, marking a critical step towards transforming cancer diagnostics. For more information, please visit https://www.qurin.com/.